Heilongjiang ZBD Pharmaceutical Co Ltd (603567) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.039x

Based on the latest financial reports, Heilongjiang ZBD Pharmaceutical Co Ltd (603567) has a cash flow conversion efficiency ratio of 0.039x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥283.54 Million ≈ $41.49 Million USD) by net assets (CN¥7.29 Billion ≈ $1.07 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. See Heilongjiang ZBD Pharmaceutical Co Ltd balance sheet independence to measure how much of total assets are equity-financed.

Heilongjiang ZBD Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)

This chart illustrates how Heilongjiang ZBD Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Check how high is Heilongjiang ZBD Pharmaceutical Co Ltd's earnings quality to evaluate the quality of earnings relative to operating cash generation.

Heilongjiang ZBD Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Heilongjiang ZBD Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company	Cash Flow Conversion Efficiency
Ta Ya Electric Wire & Cable Co., Ltd. TW:1609	-0.061x
Clean Science and Technology Limited NSE:CLEAN	0.015x
Corticeira Amorim LS:COR	0.036x
Life Healthcare JSE:LHC	0.083x
Aoyuan Beauty Valley Technology Co Ltd SHE:000615	-0.002x
WEB Travel Group Ltd AU:WEB	0.020x
Rastar Group SHE:300043	0.046x
Hiconics Drive Tech Co SHE:300048	0.010x

Annual Cash Flow Conversion Efficiency for Heilongjiang ZBD Pharmaceutical Co Ltd (2011–2024)

The table below shows the annual cash flow conversion efficiency of Heilongjiang ZBD Pharmaceutical Co Ltd from 2011 to 2024. For the full company profile with market capitalisation and key ratios, see how much is Heilongjiang ZBD Pharmaceutical Co Ltd worth.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2024-12-31	CN¥8.29 Billion ≈ $1.21 Billion	CN¥164.31 Million ≈ $24.04 Million	0.020x	+134.80%
2023-12-31	CN¥8.04 Billion ≈ $1.18 Billion	CN¥-457.90 Million ≈ $-67.00 Million	-0.057x	-23.85%
2022-12-31	CN¥7.11 Billion ≈ $1.04 Billion	CN¥-326.79 Million ≈ $-47.82 Million	-0.046x	+25.28%
2021-12-31	CN¥7.05 Billion ≈ $1.03 Billion	CN¥-433.94 Million ≈ $-63.50 Million	-0.062x	-318.25%
2020-12-31	CN¥5.50 Billion ≈ $805.28 Million	CN¥155.18 Million ≈ $22.71 Million	0.028x	-32.99%
2019-12-31	CN¥5.25 Billion ≈ $768.26 Million	CN¥220.92 Million ≈ $32.33 Million	0.042x	-42.93%
2018-12-31	CN¥4.98 Billion ≈ $729.21 Million	CN¥367.40 Million ≈ $53.76 Million	0.074x	-59.57%
2017-12-31	CN¥4.68 Billion ≈ $684.71 Million	CN¥853.19 Million ≈ $124.85 Million	0.182x	+4862.02%
2016-12-31	CN¥4.31 Billion ≈ $630.20 Million	CN¥15.83 Million ≈ $2.32 Million	0.004x	+104.52%
2015-12-31	CN¥3.98 Billion ≈ $582.63 Million	CN¥-323.90 Million ≈ $-47.40 Million	-0.081x	-145.75%
2014-12-31	CN¥2.17 Billion ≈ $317.92 Million	CN¥386.32 Million ≈ $56.53 Million	0.178x	+77.83%
2013-12-31	CN¥1.75 Billion ≈ $255.64 Million	CN¥174.68 Million ≈ $25.56 Million	0.100x	-14.48%
2012-12-31	CN¥1.32 Billion ≈ $193.04 Million	CN¥154.25 Million ≈ $22.57 Million	0.117x	+3.07%
2011-12-31	CN¥923.09 Million ≈ $135.08 Million	CN¥104.71 Million ≈ $15.32 Million	0.113x	--

About Heilongjiang ZBD Pharmaceutical Co Ltd

SHG:603567 China Drug Manufacturers - Specialty & Generic

Market Cap

$886.77 Million

CN¥6.06 Billion CNY

Market Cap Rank

#9415 Global

#2363 in China

Share Price

CN¥6.44

Change (1 day)

-2.42%

52-Week Range

CN¥4.28 - CN¥12.97

All Time High

CN¥28.17